DHT

Unknown Company

69,000
+0.00%
Data as of 2026-05-13 · Source: public Vietnamese market feeds

DHT is a Vietnam-listed stock. The latest tracked close is 69,000 VND, +0.00% on the session. Aveluro has analyzed 3 Vietnamese financial news articles mentioning DHT, with neutral as the dominant sentiment; the latest catalyst is sector sentiment: 越南最大药企外资控股趋势：DHG、IMP、DHT等被国际巨头掌控.

7.1
买入
情绪
+0.00
影响力
0.40
动量
+0.00
基本面
+0.00
成交量
1.00

Want to trade DHT? Compare brokers for Vietnam stocks.

Foreign investors need a broker that can handle Vietnam market access, settlement, custody, and foreign ownership limits.

Compare brokers

Aveluro may earn a commission from broker partners. Market data and broker availability can change; confirm access before opening an account.

价格图表
流动性
10日平均成交量
800
今日成交量
300
较均值
0.38×
流动性
低

流动性较低 — 日均成交量偏薄，较大订单可能带来更宽买卖价差和价格冲击。

新闻情绪
已分析文章
3
主要情绪
Neutral
Neutral 2
Positive 1
最新新闻
完整分析 sector sentiment May 13, 2026
越南最大药企外资控股趋势：DHG、IMP、DHT等被国际巨头掌控

Vietnam's top three pharma companies by market cap—DHG, IMP, and DHT—are now under foreign control or significant influence, with Taisho, Livzon, and ASKA as key shareholders. The sector is projected to double from $8-9 billion to $16 billion by 2032, driving M&A interest.

4 Neutral
阅读完整分析 →
Apr 11, 2026
已分类新闻 general news ↗ Vietstock - Cổ phiếu
2 +2.1 Positive
完整分析 m a announcement
中国药企Livzon收购Imexpharm（IMP）67.87%股权，越南制药业外资并购潮再起

IMP is now majority-owned by China's Livzon after a VND 6,000B deal for 67.87% of shares. The acquisition gives Livzon control of IMP's 12 EU-GMP production lines, a rare asset in Vietnam. The deal underscores a broader trend of foreign domination among top Vietnamese pharma firms, including DHG (Taisho), DMC (Abbott), and DHT (ASKA).

8 Neutral
阅读完整分析 →

所有信息仅供参考，不构成投资建议。过往表现不代表未来收益。数据来源于越南公开市场信息。

最后更新: 2026-05-13T19:05:43Z.

About · Methodology